Impact of clinical pharmacy services on renal transplant recipients’ adherence and outcomes

Rapid Communication

(2514) Views  (1149) Full article downloads

Authors: Marie A Chisholm-Burns, Christina A Spivey, Charlene Garrett, Herbert McGinty, Laura L Mulloy

Published Date October 2008 Volume 2008:2 Pages 287 - 292

DOI: http://dx.doi.org/10.2147/PPA.S4174

Marie A Chisholm-Burns¹, Christina A Spivey¹, Charlene Garrett², Herbert McGinty², Laura L Mulloy³

¹Department of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tuscon, AZ, USA; ²Medication Access Program (MAP), University of Georgia College of Pharmacy, Athens, GA, USA; ³Section of Nephrology, Hypertension and Transplantation Medicine, Medical College of Georgia School of Medicine, Augusta, GA, USA

Abstract: The purpose of this article is to provide a description of a clinical pharmacy services program implemented in a renal transplant clinic to improve medication access and adherence as well as health and economic outcomes among renal transplant recipients (RTRs). Following a team-based planning process and an informal survey of RTRs, a clinical pharmacy service intervention was implemented in the Medical College of Georgia renal transplant clinic. As part of the intervention, a clinical pharmacist reviewed and optimized medication therapy, provided instructions on how to take medication, and assisted with enrollment into medication assistance programs. Significant differences were found between RTRs who did and did not receive clinical pharmacy services on measures of adherence, health, economics, and quality of life. Clinical pharmacy services, as described in this article, have a positive impact on renal transplant recipients’ medication adherence, health and economic outcomes, and health-related quality of life. The findings described here suggest that clinical pharmacy services are a viable and effective option for improving care for RTRs in an outpatient clinic setting.

Keywords: renal transplant recipients, immunosuppressant therapy adherence, health outcomes, economic outcomes

Other articles by Professor Marie Chisholm-Burns